6.67
Schlusskurs vom Vortag:
$6.57
Offen:
$6.62
24-Stunden-Volumen:
1.05M
Relative Volume:
1.07
Marktkapitalisierung:
$334.18M
Einnahmen:
$124.00K
Nettoeinkommen (Verlust:
$-49.99M
KGV:
-3.9467
EPS:
-1.69
Netto-Cashflow:
$-31.03M
1W Leistung:
+6.72%
1M Leistung:
+40.42%
6M Leistung:
-2.49%
1J Leistung:
+10.61%
Candel Therapeutics Inc Stock (CADL) Company Profile
Firmenname
Candel Therapeutics Inc
Sektor
Branche
Telefon
617-916-5445
Adresse
117 KENDRICK STREET, NEEDHAM
Vergleichen Sie CADL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CADL
Candel Therapeutics Inc
|
6.67 | 313.14M | 124.00K | -49.99M | -31.03M | -1.69 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-30 | Fortgesetzt | H.C. Wainwright | Buy |
2025-02-20 | Eingeleitet | Citigroup | Buy |
2025-02-19 | Eingeleitet | Canaccord Genuity | Buy |
2025-02-07 | Eingeleitet | BofA Securities | Buy |
2022-12-02 | Eingeleitet | H.C. Wainwright | Buy |
2021-11-19 | Eingeleitet | BMO Capital Markets | Outperform |
2021-08-23 | Eingeleitet | Credit Suisse | Outperform |
2021-08-23 | Eingeleitet | Jefferies | Buy |
2021-08-23 | Eingeleitet | UBS | Buy |
Alle ansehen
Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten
Candel Therapeutics Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
What analysts say about Candel Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional
(CADL) Trading Report - news.stocktradersdaily.com
Is Candel Therapeutics Inc. a good long term investmentRapid growth opportunities - jammulinksnews.com
What drives Candel Therapeutics Inc. stock priceExceptional earning trajectories - jammulinksnews.com
What makes Candel Therapeutics Inc. stock price move sharplyShort Squeeze Radar - beatles.ru
Candel Therapeutics (CADL) Shares Soar 9.60% - AInvest
Candel Therapeutics (CADL) Has a New Rating from Freedom Capital Markets - The Globe and Mail
Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating - Investing.com Nigeria
Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating By Investing.com - Investing.com South Africa
(CADL) Investment Report - news.stocktradersdaily.com
Brookline Capital Initiates Candel Therapeutics(CADL.US) With Buy Rating, Announces Target Price $25 - 富途牛牛
Candel Therapeutics Added to Russell Indexes, Analysts Forecast Upside of 319.85% - AInvest
Candel Therapeutics added to multiple Russell value indexes By Investing.com - Investing.com South Africa
Brookline Capital initiates Candel Therapeutics stock with Buy rating, $25 target - Investing.com Nigeria
Candel Therapeutics Added To Multiple Russell Value Indexes In 2025 Reconstitution - 富途牛牛
Market movers: Meta, Nvidia, Candel Therapeutics, Ocean Power Technologies... - Proactive financial news
Candel Therapeutics: Russell Inclusion and Clinical Catalysts Drive Biotech Upside - AInvest
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution - The Manila Times
Candel Therapeutics added to multiple Russell value indexes - Investing.com
Candel Therapeutics, Inc. Gains Inclusion in Multiple Russell Value Indexes During 2025 Annual Reconstitution - Quiver Quantitative
Candel Therapeutics Expands Russell Index Presence with - GlobeNewswire
Candel Therapeutics expands Russell Index presence following 2025 reconstitution - Proactive financial news
Candel Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com India
One Candel Therapeutics Insider Raised Stake By 22% In Previous Year - Yahoo Finance
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Market movers: Carnival, Uber, Ideal Power, Candel Therapeutics... - Proactive Investors
Candel Therapeutics names Charles Schoch as CFO after interim tenure - Proactive financial news
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer - The Globe and Mail
Trend Tracker for (CADL) - news.stocktradersdaily.com
Candel Therapeutics Elects New Directors at Annual Meeting - TipRanks
Candel Therapeutics, Inc.'s (NASDAQ:CADL) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures - simplywall.st
Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire
Candel Therapeutics, Inc. (NASDAQ:CADL) Shares Purchased by Squarepoint Ops LLC - Defense World
Candel Therapeutics appoints new board member ahead of BLA submission By Investing.com - Investing.com South Africa
Small cap wrap: HIVE Digital, TNR Gold, Candel Therapeutics... - Proactive financial news
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., To Board - citybiz
Candel Therapeutics, Inc. Appoints Maha Radhakrishnan to Its Board of Directors - marketscreener.com
Candel Therapeutics adds biotech veteran Maha Radhakrishnan to Board - Proactive financial news
Candel Therapeutics appoints new board member ahead of BLA submission - Investing.com
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors - GlobeNewswire
Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):